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A B S T R A C T
Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a widespread highly toxic environmental contami-
nant, suppresses immune response and leads to an increased susceptibility to infectious agents. In particular,
several studies have provided evidence that TCDD decreases resistance to numerous viruses. Indeed, in vivo and
in vitro investigations showed that the presence of TCDD is able to interfere with the replication of both human
and animal viruses, such as inﬂuenza A viruses, coxsackie virus B3, immunodeﬁciency virus type-1 (HIV-1),
cytomegalovirus (CMV), herpes simplex II, and bovine herpesvirus 1. Moreover, TCDD could induce an
exacerbation of latent infection produced by HIV-1, CMV or Epstein-Barr virus. In this review, we ﬁrst describe
the general eﬀects of TCDD exposure on mammalian cells, then we focus on its inﬂuence on the viral infections.
Overall, the available data support the concept that TCDD exposure may act as an additional risk factor in
promoting of viral diseases.
1. Introduction
Several studies have established that the immune system is one of
the most liable targets for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),
a widely distributed and persistent environmental contaminant, also
known as dioxin. Although cellular and molecular mechanisms of
TCDD immunotoxicity are not well identiﬁed, suppressed humoral and
cell-mediated immune responses, as well as decreased host resistance
to infectious disease have been observed in experimental animals
(Thigpen et al., 1975; Luster et al., 1979; Clark et al., 1981, 1983;
House et al., 1990; Funseth and Ilbäck, 1994; Yang et al., 1994;
Garssen et al., 1995; Burleson et al., 1996; Warren et al., 2000; Funseth
et al., 2000, 2002; Nohara et al., 2002; Vorderstrasse et al., 2003;
Kerkvliet, 1995; Mandal, 2005; Ilbäck and Friman, 2007; Fracchiolla
et al., 2011; Phadnis-Moghe et al., 2016). Low-dose exposure of both
humans and animals to environmental pollutants may inﬂuence the
immune system and the pathogenesis of various infectious diseases.
Indeed, many studies have shown that the suppression of the immune
system is typically associated with an increased susceptibility and
severity of infective pathologies. In particular, as reviewed by Ilbäck
and Friman (2007), the environmental contaminants may inﬂuence the
virulence of microorganisms and/or the susceptibility to infections
among hosts. In addition, there is an emerging suggestion that
maternal and early-life exposures to common environmental contami-
nants may have a critical impact on susceptibility to infection later in
life (Nagayama et al., 2001; ten Tusscher et al., 2003; Smith et al.,
2008; Leijs et al., 2009; Winans et al., 2011;). The earliest evidence
describing the eﬀects of TCDD on infectious diseases was shown by
Thigpen et al. (1975), who reported that extremely low levels of TCDD
exposure in mice followed by infection with Salmonella bern resulted
in an increased mortality and a decreased time range from infection to
death. Conversely, in the case of Herpesvirus suis infection (also known
as pseudorabies virus) TCDD had no signiﬁcant eﬀect on mortality in
the pseudorabies-infected mice. These authors concluded that the
exposure to very low doses of environmental contaminants, such as
TCDD, has the capacity to aﬀect host defense. After Thigpen's paper, in
the last 40 years, many research teams have described that dioxin
exposure negatively aﬀects the resistance to numerous infectious
agents such as bacteria, viruses, and parasites. In this paper we focus
on viruses infections (Tables 1 and 2), especially reviewing the
biological eﬀects of the cellular exposition to dioxin on the both the
progression and the outcome of the infective disease.
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2. TCDD
TCDD is a prototype of a group of compounds named as poly-
halogenated aromatic hydrocarbons. It is well established that TCDD is
not intentionally generated. Indeed, it is a byproduct of some industrial
processes, including chlorination of phenolic substances; however
uncontrolled waste combustion actually represents the largest source
of dioxin as pollutant. TCDD is persistent in the environment and
bioaccumulative in living organisms. Because of its highly lipophilic
nature, dioxin shows a special tropism for adipocytes tending to
accumulate in the adipose fraction of body tissues and organs.
Humans are generally exposed to this type of environmental toxins
through the dermal absorption but mainly via the dietary intake.
Indeed, through the food chain TCDD is incorporated into products of
animal origin naturally rich in fat, such as milk, cheese, meat, and
seafood, as well as in drinking water, soil, dust, smoke, and air. From
the bioorganic accumulation sites, TCDD can be released slowly over
the years to produce a variety of biological eﬀects over time. Although
currently other mechanisms cannot be excluded, the main molecular
mechanism of action by which TCDD exerts its biochemical eﬀects in
vertebrate species is through the Aryl hydrocarbon Receptor (AhR)
stimulation, a ligand-activated transcription factor belonging to the
basic helix-loop-helix-PER-ARNT-SIM superfamily of proteins. In the
AhR signaling pathway the activation of AhR results in its dissociation
from the Hsp90/XAP2/p23 chaperone proteins complex and following
dimerization with aryl hydrocarbon receptor nuclear translocator
(ARNT) (Hogenesch et al., 1997; Kazlauskas et al., 2000; Mulero-
Navarro and Fernandez-Salguero, 2016). The AhR/ARNT complex
translocates into nucleus where it interacts with aryl hydrocarbon
responsive elements (AhREs) in the promoter of various AhR-respon-
sive genes activating their transcription (Beischlag et al., 2008).
Binding of AhR/ARNT leads to several biological and toxicological
eﬀects including induction of numerous phase I and II xenobiotic-
metabolizing enzymes as cytochrome P-450 isoforms, particularly
CYP1A1, CYP1A2, CYP1B1, CYP2A1, and UDP-glucuronosyl transfer-
ase UGT1A6 (Zhang et al., 1998; Okino and Whitlock, 1995; Ko et al.,
1996; Mandal, 2005; Amenya et al., 2016). In addition, several other
genes are transcriptionally regulated by AhR activation, as cell cycle
proteins, ribosyltransferases, cell adhesion proteins and others (Ma
et al., 2001; Denison et al., 2011). Emerging evidence indicates that the
activation of AhR inﬂuences host cell responses to viral infection
through immunomodulation (Sulentic et al., 2000; Lawrence and
Vorderstrasse, 2004; Vorderstrasse et al., 2004; Head and Lawrence,
2009; Boule et al., 2014; Phadnis-Moghe et al., 2016). Dioxin can
provoke a wide range of tissue- and species-speciﬁc toxic eﬀects, such
as chloracne (a persistent cystic and hyperkeratotic skin condition),
gastric epithelial hyperplasia, liver damage, disruption of hormone
signaling pathways, reproductive and developmental defects, immuno-
toxicity, wasting syndrome, changes in sex ratio, and several types of
cancer (Mandal, 2005; White and Birnbaum, 2009). In addition,
Germolec et al. (2012) have recently reported that TCDD can promote
autoimmunity following exposure during fetal or early neonatal devel-
opment. For example, a single exposure to TCDD during mid gestation
was shown to slightly enhance anti-DNA antibodies and/or glomerular
immune complex deposits in non-autoimmune C57BL/6 or lupus-
predisposed SNF1 mice. Moreover, neonatal exposure of NFS/sld mice
to TCDD induced a Sjögren's syndrome-like disease along with
increased anti-SS-A/Ro and anti-SS-B/La autoantibodies. As reviewed
by White and Birnbaum (2009), the history of anthropogenic dioxin
production and dioxin poisoning is very old and still continues now.
The earliest evidence of man-made dioxin molecules comes from a
chemical production plant in Germany that manufactured washing
soda. Chloracne, which represents a characteristic sign of dioxin
exposure, was ﬁrst described in German industrial workers in 1897.
In general, most reported human exposures have been the result of
unintentional production or spills, as was the case for its formation as a
byproduct of Agent Orange, an herbicide containing 2,4,5-trichloro-
phenoxyacetic acid (2,4,5-T) and contaminated with dioxin. Agent
Orange was widely used as a defoliant in Vietnam, between 1962 and
1970, during the Vietnam war, and persistent chloracne was observed
in exposed people. The American military exposure to Agent Orange
was also associated with an increased risk of diabetes and of soft-tissue
sarcomas, non-Hodgkin's lymphoma, Hodgkin's disease, and chronic
lymphocytic leukemia (Michalek and Pavuk, 2008). In 1976, in Seveso
(Italy), an explosion taken place at a plant producing 2,4,5-trichlor-
ophenol, a compound developed during the synthesis of 2,4,5-T. As
consequence, some weeks after the explosion, several exposed people
developed skin lesions as chloracne. In the following years, studies in
the exposed people provided evidence on the possible role of TCDD as a
Table 1
Summary of investigations showing that TCDD is able to interfere with the replication of
human viruses..
Virus In vivo In vitro Reference
Inﬂuenza A viruses
A/Taiwan/1/64 (H2N2) B6C3F1 mice – (House et al.,
1990)
Rat-adapted inﬂuenza
virus (RAIV)
Fischer 344 rats – (Yang et al., 1994)
A/Hong Kong/8/68
(H3N2)
B6C3F1 mice – (Burleson et al.,
1996)
A/HKx31 (H3N2) C57Bl/6 mice – (Warren et al.,
2000)
A/PR/34/8 (H1N1) B6C3F1
(C57Bl/
6×C3H),
– (Nohara et al.,
2002)
BALB/c,
C57Bl/6N,
DBA2mice
A/HKx31(H3N2) C57Bl/6 mice – (Vorderstrasse
et al., 2003)
Human coxsackievirus
B3
A/J-mice – (Funseth and
Ilbäck, 1994)
(Funseth et al.,
2000, 2002)
Human
immunodeﬁciency
virus-1 (HIV-1)
– MT-4
cells
(Pokrovsky et al.
1991)
HIV-1 – U1 cells (Gollapudi et al.,
1996)
HIV-1 – OM 10.1
cells
(Ohata et al.,
2003)
Herpesviruses
Herpesvirus suis C57BL/6Jfh
(J67) mice
– (Thigpen et al.,
1975)
Herpesvirus II C57Bl/6 mice – (Clark et al., 1983)
Cytomegalovirus (CMV) TOX-Wistar rats – (Garssen et al.,
1995)
CMV – MRC-5
cells
(Murayama et al.,
2002)
Epstein-Barr virus
(EBV)
– COS7;
MCF7
cells
(Kashuba et al.,
2006)
EBV – B95-8;
P3HR1
cells
(Inoue et al.,
2012)
Table 2
Summary of investigations showing that TCDD is able to interfere with the replication of
animal viruses..
Virus In vivo In vitro Reference
Bovine herpesvirus
1 (BHV-1)
– MDBK cells (Fiorito et al., 2008a,b, 2010,
2013, 2014a, 2014b)
(Santamaria et al., 2011;
Fiorito and De Martino,
2014)
BHV1 Cattle – (Fiorito et al., 2015)
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human carcinogen and to enhance risk for cardiovascular diseases,
diabetes, and as endocrine disruptor. In particular, studies of surveil-
lance on Seveso people reported an excess of lymphatic and hemato-
poietic tissue neoplasms (Pesatori et al., 2009), an increased all-cancer
mortality 15–20 years after exposure among those living in the most
contaminated area (Pesatori et al., 2009; Boﬀetta et al., 2011), or a
modiﬁed neonatal thyroid function subsequently to the ﬁrst exposure
(Baccarelli et al., 2008). After the Seveso accident, studies in rats
showed that two-year chronic exposure to TCDD at low dose, as
0.01 μg/kg/day, induced an increased risk of hepatocellular carcino-
mas as well as various squamous cell carcinomas (Kociba et al., 1978,
1979; White and Birnbaum, 2009). Finally, one of the most recent
episodes involved the ukrainian Prime Minister Victor Yushchenko,
who was intentionally poisoned with TCCD in 2004. Before the
presidential election, Yushchenko was aﬀected ﬁrst by acute pancrea-
titis, then by profound facial acne and edema. The excess of dioxin
levels in his blood samples revealed chloracne (Saurat et al., 2012). In
human, the maximum tolerable daily intake is 4 pg/kg, while
Yushchenko had a single dose of 20 μg/kg. Indeed, he received a single
oral dose of about 5 million-fold higher than the tolerable daily intake
in human (Saurat et al., 2012). Skin lesions were hamartomas,
accompanied by a complete involution of sebaceous glands (Saurat
et al., 2012). Furthermore, a clinical study on the TCDD poisoning in
Yushchenko reported the identiﬁcation and measurement of two TCDD
metabolites - 2,3,7-trichloro-8-hydroxydibenzo-p-dioxin and 1,3,7,8-
tetrachloro-2-hydroxydibenzo-p-dioxin, - identiﬁed in the faeces, blood
serum, and urine. The half-life of TCDD in Yushchenko was 15.4
months (Sorg et al., 2009).
Several studies, including our recent ﬁndings, demonstrate the
involvement of dioxin in the genesis of tumors. Although the molecular
mechanisms for carcinogenicity by dioxin have not been elucidated
until now, in 1997 TCDD was classiﬁed as a cancer promoter by the
International Agency for Research on Cancer (IARC, 1997). This
classiﬁcation is based on studies performed in laboratory animals
showing that TCDD induces the formation of neoplastic lesions in the
liver, lung, oral mucosa and skin. For instance in mice, exposure to
TCDD stimulates the proliferation of epithelial cells within the skin
tissue in a tissue-dependent manner, as well as increases proliferation
of cultured cells, such as human keratinocytes (Ray and Swanson,
2009), late gestational ureteric cells (Bryant et al., 2001), human breast
cells (Ahn et al., 2005), and bovine kidney cells (Fiorito et al., 2008a,
2011). By examining the tumor-promoting activities of dioxin, these
ﬁndings are in accordance with a previous study indicating that
epithelial cells are the most responsive to the dioxin eﬀects (Poland
et al., 1982).
3. TCDD and the human viruses
3.1. TCDD and inﬂuenza A viruses
In general, the most published research ﬁndings concern the eﬀects
of dioxin on inﬂuenza virus infections. Several kinds of environmental
contaminants could contribute to the development of respiratory
diseases. For example, heavy metals, like cadmium, whose sources
are mainly food consumption, soil and cigarette smoke, may induce
oxidative stress which directly enhances the ability of inﬂuenza virus to
replicate in the host cell (Checconi et al., 2013). Respiratory infections
are among the top 10 leading causes of death, and common respiratory
pathogens such as inﬂuenza viruses may cause pandemic disease. Many
studies have proposed that AhR activation can involve both leukocytes
and non-immune cells by using inﬂuenza A virus as a model of
respiratory viral infection. Thus, functional changes as suppressed
lymphocyte responses and increased inﬂammation in the infected lung
were observed. Indeed, one of the most adverse eﬀects of TCDD is
represented by a decrease in host resistance to inﬂuenza A virus (House
et al., 1990; Burleson et al., 1996; Warren et al., 2000; Vorderstrasse
et al., 2003; Teske et al., 2008; Head and Lawrence, 2009; Jin et al.,
2010; Boule et al., 2014). House et al. (1990) described a signiﬁcant
dose-related suppression in induction of both IgM and IgG antibody-
forming cells in adult female B6C3F1 mice after administration of a
single dose of TCDD at 10, 1.0, or 0.1 μg/kg, and TCDD exposure
induced an increased mortality of mice to inﬂuenza A/Taiwan/1/64
(H2N2) virus.
In Fischer 344 rats the administration of 3.0 and 10.0 μg/kg TCDD
provoked a suppression of inﬂuenza virus-augmented natural killer
(NK) cells activity, while the spontaneous NK activity was not aﬀected
(Yang et al., 1994). Burleson et al. (1996) showed that a single dose of
TCDD at 0.10, 0.05, or 0.01 μg/kg induced an increase in mortality to
inﬂuenza A/Hong Kong/8/68 (H3N2) virus when mice were chal-
lenged 7 days after TCDD administration. In addition, Vorderstrasse
et al. (2003) carried out experiments in C57Bl/6 mice treated with 1,
2.5, 5, 7.5 or 10 μg/kg TCDD one day prior to inﬂuenza virus challenge.
In sacriﬁced mice the authors evidenced that lymphocyte migration to
the lung and the production of virus-speciﬁc IgG2a, IgG1, and IgG2b
antibodies were signiﬁcantly reduced, even at the lower doses, while
IgA were signiﬁcantly enhanced in all groups treated with TCDD.
TCDD exposure also induced an increase in pulmonary neutrophilia in
infected mice. The authors thereby have suggested that decreased
antibody production and increased inﬂammation might contribute to
the death of mice exposed to TCDD. Warren et al. (2000) reported that
a single oral dose of 1–10 μg TCDD/kg caused death in mice infected
with a non-lethal inﬂuenza A virus (A/HKx31). With reference to
inﬂuenza A virus infection, however, these authors also showed that
mortality varied widely between experiments at equivalent doses of
TCDD. In this context, Nohara et al. (2002) have suggested that the
apparent discrepancies in the eﬀects of TCDD described above may be
due to many factors, including combinations of TCDD levels of
exposure and mouse strain used. Intriguing, in order to conﬁrm
whether TCDD at doses as low as 10 ng/kg increased the mortality of
inﬂuenza A virus-infected mice as reported by Burleson et al. (1996),
Nohara et al. investigated the eﬀect of TCDD in the dose range of 0–
500 ng/kg on the mortality of mice infected with inﬂuenza A type virus
A/PR/34/8. They also explored the sex- and strain-dependency of host
resistance in male B6C3F1 mice and in female C57Bl/6, BALB/c, and
DBA/2 mice by administering the same dose range of TCDD. Their
results demonstrated that TCDD doses up to 500 ng/kg did not
increase the mortality of virus-infected mice in any of the strains. As
consequence, these authors conclude that the increase in mortality
caused by TCDD in inﬂuenza A virus infection is not caused by host
resistance impairment, but to an as yet unknown mechanism (Nohara
et al., 2002). We hypothesize that TCDD exposure coupled to viral
infection may induce a variety of biological eﬀects also depending by
the viral subtype.
3.2. TCDD and coxsackieviruses
The coxsackieviruses belong to the enteroviruses, which are re-
sponsible for some enteroviral infections in humans; nevertheless the
majority of these does not determine apparent symptoms, or at most
causes simply minor illness related to the upper respiratory or
gastrointestinal tract. Rarely coxsackie B viruses may provoke myo-
carditis, pancreatitis, or meningoencephalitis. The group of Ilbäck
described that A/J-mice were infected with the human coxsackievirus
B3 (CB3) and then injected, at 4 and 7 days of the infection, with [14C]
TCDD (about 65 μg/kg). One day after TCDD treatment, the authors
detected an increased TCDD uptake in spleen, thymus, heart, pancreas,
liver and brain during the CB3 infection, and this increased uptake was
signiﬁcantly most marked both on day 4 and 7 post inoculation
(Funseth and Ilbäck, 1994). Subsequently, the same group described
that A/J mice, one day before infection with CB3, were injected
intraperitoneally with 3H-TCDD (about 0.5 μg TCDD/kg). Then, at
diﬀerent days various body organs and tissues -including spleen,
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thymus, heart, pancreas, liver, thyroid, skeletal muscle, adipose tissue,
lung, kidney, adrenals, testis, epididymis, brain and blood - were
collected. The authors showed that a common infection with CB3 in
mice causes redistribution of a beforehand accumulated environmental
pollutant, resulting in increased concentrations and increased toxicity
in target organs, such as thymus and brain (Funseth et al., 2000). In
addition, mice exposed to TCDD had a decreased ability to survive
infection with CB3 (Funseth et al., 2002).
3.3. TCDD and human immunodeﬁciency virus - 1
Human immunodeﬁciency virus-1 (HIV-1), a cytopathic retrovirus,
is the primary etiological agent of acquired immunodeﬁciency syn-
drome (AIDS). In MT-4 cell cultures (human leukemia T cells) infected
by HIV-1 virus, a signiﬁcant increase of virus production after in vitro
treatment with 10–150 nM TCDD has been showed by Pokrovsky et al.
(1991). Gollapudi et al. (1996) reported that dioxin (10–200 nM)
triggers HIV-1 gene expression, causing an increased production of
HIV in chronically infected promonocytic U1 cells. This dioxin eﬀect
seems to be mediated, at least partially, by activation of nuclear factor
kappa-B, a key cellular transcription factor that regulates HIV-replica-
tion playing a key role in the induction of both HIV and cytokine genes.
In addition, TCDD stimulated the production of tumor necrosis-α in U1
cells. Therefore the authors have suggested molecular alterations for
increased viral replication in cells exposed to dioxin (Gollapudi et al.,
1996). Furthermore, Ohata et al. (2003) indicated that TCDD (10 nM)
activates HIV-1 replication in promyelocytic OM 10.1 cell line, latently
infected with HIV-1. The authors concluded that HIV-1 infected
individuals chronic exposure to polyhalogenated aromatic hydrocar-
bons, such as TCDD, may contribute to the clinical development of
AIDS.
3.4. TCDD and herpesviruses
As reported above, Thigpen et al. (1975) argued that oral doses of
1–20 μg TCDD/kg per week for 4 weeks had no eﬀect on the mortality
of mice infected with Herpesvirus suis. Conversely, studies with
herpesvirus II (HSV-II), indicate an increased mortality by TCDD
intraperitoneally injected in mice once a week for 4 weeks at doses of
0.04, 0.4, or 4.0 µg/kg (total dose of 0.16, 1.6, and 16.0 μg/kg) (Clark
et al., 1983).
Cytomegalovirus (CMV) is an ubiquitous herpesvirus contracted by
50–90% of normal adults, depending on geographic location. In
particular, CMV infects most individuals early in life and establishes
thereafter a lifelong latent infection characterized by the persistence of
viral genome without the production of infectious virions. Latently
infected CMV is frequently activated in immunocompromised indivi-
duals. Garssen et al. (1995) showed that viral titers in the salivary
glands of rats infected with CMV are elevated by dioxin exposure in
vivo. Treatment of MRC-5 cells, a human embryonic ﬁbroblast cell line,
with 0.0001 pg/ml TCDD increased the cytopathic eﬀects on CMV-
infected cultures and the cytomegalovirus replication with a concomi-
tant increase in CMV UL54 DNA levels. Moreover, CMV-infected MRC-
5 cells increased gene expression via AhR stimulation. These results
suggest that TCDD may contribute both to the development of
opportunistic diseases by reactivation of latent CMV infection and to
the regulation of CMV replication through the AhR inﬂuence
(Murayama et al., 2002).
Epstein-Barr virus (EBV) is an ubiquitous herpesvirus that infects
more than 90% of the world's population. Generally, the infection is
asymptomatic and the virus establishes latently in resting recirculating
memory B cells (Babcock et al., 1998). B cells are a main component of
humoral immunity and represent a sensitive target for TCDD through
an induction of AhR gene and protein expression (Sulentic et al., 1998;
Suh et al., 2002; Sulentic and Kaminski, 2011; Phadnis-Moghe et al.,
2016). Moreover, several studies demonstrated that AhR interacts
directly with viral proteins and aﬀects viral latency. In fact, it has been
observed that the EBNA-3, an EBV-encoded nuclear antigens required
for immunoblastic transformation and continuous proliferation of B-
cells, interacts speciﬁcally with AhR (Kashuba et al., 2006). Following
activation of the AhR, EBNA-3 is able to counteract the inhibitory eﬀect
of TCDD on the growth of EBV-carrying lymphoblasts (Kashuba et al.,
2006). Inoue et al. (2012) evaluated the possibility that ligand-
activated AhR reactivates EBV. The induction of lytic cycle produces
new viral infection and EBV-associated cellular transformation, and
this induction could represent a risk factor for both malignant
transformation and the development of autoimmune diseases, such
as Sjögren's syndrome. Those studies were performed on saliva
samples collected from patients with primary Sjögren's syndrome,
from healthy controls and patients with severe dry mouth. TCDD (1–
100 nM) enhanced the EBV BZLF1 gene transcription, which mediates
the switch from the latent to the lytic form of EBV infection in EBV-
positive B cell lines and in a salivary gland epithelial cell line. In
addition, TCDD-induced increases in BZLF1 mRNA and EBV genomic
DNA levels in the B cell lines. The authors conclude that AhR ligands,
such as TCDD, are able to induce the EBV reactivation in activated B
cells and salivary epithelial cells, and these ligands are involved in
Sjögren's syndrome. Jointly these ﬁndings may account for the
immunological disturbances and exacerbation of latent EBV infections
frequently observed during the prolonged exposure to xenobiotics
(Stancek et al., 1995).
4. Dioxin and the animal viruses
Over the past decade, high levels of TCDD have been detected in
dairy products from some areas of Campania Region (Italy) (Diletti
et al., 2003; Santelli et al., 2006; Esposito et al., 2009, 2010) where
bovine herpesvirus 1 (BHV-1) is widespread (2004/558/EC, 2004;
Ackermann and Engels, 2006). BHV-1, one of the most important viral
pathogen of cattle, has been studied by the Section of Infectious
Diseases at the Department of Veterinary Medicine and Animal
Production (University of Naples Federico II, Naples, Italy) for over
30 years (Martone et al., 1981; De Martino et al., 2003a, 2003b, 2007).
Thus, during “dioxins crisis”, we started to study the eﬀect of TCDD on
BHV-1, an animal virus. As a member of the alpha-herpesvirinae
subfamily, BHV-1 is an important pathogen responsible for infectious
bovine rhinotracheitis (IBR), infectious pustular vulvovaginitis (IPV),
conjunctivitis, abortions as well as shipping fever, a complicated
infection of the upper respiratory tract. Moreover, BHV-1 may induce
immunosuppression, thus rendering cattle more susceptible to second-
ary bacterial infections, and leading to pneumonia and occasionally to
death (Tikoo et al., 1995; Jones, 2003). In Madin-Darby Bovine Kidney
(MDBK) cell line, an epithelial-like bovine cell line commonly used for
growing and assaying BHV-1 (Shrivastava and Le Jan, 1982; De
Martino et al., 2003a, 2003b), our research group has detected the
presence of AhR (Fiorito et al., 2014a). In this in vitro experimental
model, we have demonstrated that TCDD induces signiﬁcant cell
proliferation (Fiorito et al., 2008a) and also impairs cellular iron
homeostasis, leading ultimately to important changes in the intracel-
lular labile iron pool extent (Santamaria et al., 2011). In line with many
recent reports, cell growth modiﬁcations coupled to iron homeostasis
impairment could be associated to the neoplastic transformation of the
bovine cells and to cancer development (Toyokuni, 2009; Fiorito et al.,
2011; Fiorito and De Martino, 2014). Analysis of MDBK cultured
monolayers morphology revealed some death alterations in a large
number of exposed cells, without however apoptosis and/or necrosis
hallmarks; we rather found that dioxin activated cell death by
autophagy (Fiorito et al., 2008a; Fiorito et al., 2011). Hence, dioxin
initiates divergent pathways of cell proliferation and autophagic cell
death in an epithelial kidney cell line. In this way our data establish the
requirement for autophagy in the maintenance of MDBK cells exposed
to dioxin, providing that autophagy protects against proliferative
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eﬀects induced by non-genotoxic compounds such as TCDD. Indeed
autophagy serves as a protective mechanism, though persistent activa-
tion of autophagy can result in cell death, mainly following exposure to
toxic agents (Fiorito and De Martino, 2014). In the same bovine kidney
cells infected with BHV-1 (Cooper strain) and concurrently exposed to
diﬀerent TCDD concentrations (0.01, 1 and 100 pg/ml), we showed
that dioxin signiﬁcantly enhances BHV-1 replication in a concentra-
tion-dependent manner, increasing both cytophatic eﬀect and viral
titer (Fiorito et al., 2008a; Fiorito et al., 2014b). Moreover, during
BHV-1 infection, the expression of AhR was not inﬂuenced by viral
infection, whereas TCDD induced a signiﬁcant AhR overexpression
(Fiorito et al., 2014a).
It is known that BHV-1 induces apoptosis which occurred only
during the late stages of infection (Devireddy and Jones, 1999; Geiser
et al., 2008; Fiorito et al., 2008b). The presence of TCDD anticipates
BHV-1-induced apoptosis by accelerating the activation of initiator
caspases 8 and 9, and of executioner caspase 3, through modulation of
the Bcl-2 family members (Fiorito et al., 2008b). Therefore our data
provide evidence that in the presence TCDD BHV-1 induces high levels
of apoptosis in MDBK cells throughout the early stages of infection.
Although epithelial cells are more resistant to apoptosis (Wesselborg
et al., 1993), our ﬁndings show a signiﬁcant rate of apoptosis by now in
the early stages of infection, suggesting that the concomitant cell
exposure to TCDD may enhance apoptosis (Fiorito et al., 2008b).
More on this topic, in a previous paper our group showed that,
during the early stages of infection in MDBK cells, BHV-1 signiﬁcantly
up-regulates telomerase activity, through a involvement of an immedi-
ate-early viral gene (Pagnini et al., 2006). While, during the late phases
of infection, when BHV-1-induced apoptosis takes place (Devireddy
and Jones, 1999; Fiorito et al., 2008b), we observed a down-regulation
of telomerase activity (Fiorito et al., 2014a). Telomerase is a ribonu-
cleoproteic enzyme complex which consists of an essential RNA
component and a catalytic protein subunit containing the telomerase
reverse transcriptase activity. Human telomerase reverse transcriptase
(hTERT) catalytic subunit is a protein up-regulated by c-Myc (Wu
et al., 1999). Following BHV-1 infection in MDBK cells, we found that
TCDD may act as a strong inhibitor of telomerase activity (Fiorito et al.,
2014a). In fact, TCDD considerably and signiﬁcantly induced a down-
regulation of telomerase activity, when anticipated virus-induced
apoptosis occurred, by using the same experimental conditions
(Fiorito et al., 2008b, 2014a). These results were observed along with
reduced levels of bovine TERT (bTERT) and of c-Myc in BHV-1
infected cells in the presence of dioxin (Fiorito et al., 2014a).
Gene expression of BHV-1 is temporally expressed in three
diﬀerent phases identiﬁed as immediate-early (IE), early (E), and late
(L), and tissue-speciﬁc factors may mediate latency and/or pathogen-
esis by inﬂuencing viral gene expression (Jones, 2003). Immediate-
early BHV-1 infected cell protein 0 (bICP0), the bovine homologue of
HSV-1 ICP0, controls the three phases of BHV-1 replication, by playing
a role of strong activator or repressor of speciﬁc viral promoters (Wirth
et al., 1991; Jones et al., 2006). During BHV-1 infection in bovine
kidney cells, TCDD induced an increase of expression levels of both
bICP0 gene and protein, as well as an anticipation of bICP0 in the
cytoplasm (Fiorito et al., 2011). Consequently, we suppose that the
accelerated down-regulation of telomerase activity may be the result of
a correlation between bICP0 and dioxin. In fact, Pagnini et al. (2006)
also observed that an immediate-early viral gene mediated the mod-
ulation of telomerase activity produced by BHV-1 (Fiorito et al.,
2014a).
Still with reference to animal viruses and according with literature,
DNA viruses such as BHV-1 require an iron-replete cell host to
eﬃciently reproduce; iron bioavailability become thereby a crucial
factor for viral cycle as well as for viral DNA replication (Lamarche
et al., 1996; Maﬀettone et al., 2008; Rashed, 2011). In particular, we
have provided evidence that TCDD impairs cellular iron homeostasis in
mammalian cells by modulating the expression of the main cellular
proteins involved in iron metabolism, leading ultimately to important
changes in the extent of the labile iron pool (Santamaria et al., 2011).
Taking into account that TCDD enhances the BHV-1 replication, we
have also explored the eﬀects of TCDD on iron metabolism during
BHV-1 infection in MDBK cells, ﬁnding that they cause a divergent
modulation of Iron Regulatory Proteins RNA-binding activity with an
up-regulation of transferrin receptor 1 and a concomitant down-
regulation of ferritin. This situation leads to an increase in intracellular
iron content that might promote the onset of BHV-1 infection and
render bovine cells even more susceptible to viral infection (Fiorito
et al., 2013).
Overall, these ﬁndings suggest that TCDD exposure may act as an
additional risk factor for the progression of BHV-1 infection in
mammalian cells (See Diagram in Fig. 1 – Table 2). Finally, as reported
above, to monitor PCDD/Fs levels in cow's and buﬀalo's milk from
farms an extraordinary plan of oﬃcial control was carried out in 2008
in Campania region. The most part of the non-compliant farms were
individuate in a restricted area of region by geo-referencing analysis
(Esposito et al., 2009, 2010). In the same period, to verify the
possibilities of the use of data obtained in vitro to in vivo conditions,
in those farms where PCDD/Fs monitoring was carried out (Esposito
et al., 2009, 2010), we have performed an epidemiological analysis on
the distribution of BHV-1 in cattle (Fiorito et al., 2015). To detect
antibodies for IBR from cattle raised on those farms, serum and plasma
Fig. 1. Schematic diagram illustrating the hypothesized mechanisms as to how TCDD exerts its eﬀects on the BHV-1 replication, resulting in anticipated apoptotic cell death and
increased virus replication.
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samples were collected. By using IBR-gB and IBR-gE E.L.I.S.A. kit,
which represents the test procedure of choice in many European IBR
programs, we have revealed a signiﬁcant prevalence of IBR on samples
collected from farms in contaminated areas, compared to samples
collected in uncontaminated areas. Hence, TCDD may inﬂuence BHV-1
infection, promoting a signiﬁcant prevalence of IBR in cattle (Fiorito
et al., 2015). Moreover, we hypothesize that dioxin may also act as
additional risk factor for progression of IBR in cattle, provoking animal
diseases and economic losses to the cattle industry.
5. Conclusion
TCDD is a widespread, persistent, and highly toxic environmental
pollutant. By acting in an orchestrated manner, dioxin can suppress
immune response thereby leading to an increased susceptibility to
infectious agents. Throughout this review is highlighted how the
presence of dioxin is able to modify the replication of several viruses.
Thus, TCDD-mediated AhR activation can act on host cell responses to
inﬂuenza A viruses through immunomodulation. More, dioxin en-
hances viral replication, precisely in CB3, HIV-1, CMV, HSV-II, or in
BHV-1 infections. In this context, AhR may interact directly with viral
proteins and aﬀect viral latency, as observed in EBV, HIV, CMV
infections following exposure to xenobiotics, such as TCDD. In addi-
tion, TCDD signiﬁcantly reduces telomerase activity when anticipated
BHV-1-induced apoptosis occurred, as well as by interfering with iron
homeostasis increases the free intracellular iron availability thereby
promoting the onset of BHV-1 infection in bovine cells. Furthermore,
TCDD inﬂuences BHV-1 infection, promoting a signiﬁcant prevalence
of IBR in contaminated cattle. Hence, the activation of AhR by TCDD
can be associated with decreased host response and reduced survival in
vivo, and with the onset of viral infections in vitro. On the whole, the
available data support the concept that TCDD exposure may act as a
risk factor for the progression of viral diseases. However, further
studies are required to better characterize the biological eﬀects of
dioxin on viral diseases in humans as well as in animals.
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